98 related articles for article (PubMed ID: 30534678)
21. Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds.
Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Risler R; Pathare PM; Quinn J; Vessella RL; Foulon C; Zalutsky M; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2004; 15(1):203-23. PubMed ID: 14733601
[TBL] [Abstract][Full Text] [Related]
22. 211 At-Astatination of Arenes Using Trimethylgermanyl Precursors.
Muller M; Battisti UM; Zabrocki M; Hansson E; Jensen H; Aneheim E; Lindegren S; Herth M
Chempluschem; 2024 Jun; ():e202400254. PubMed ID: 38877386
[TBL] [Abstract][Full Text] [Related]
23. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers.
Vaidyanathan G; Boskovitz A; Shankar S; Zalutsky MR
Peptides; 2004 Dec; 25(12):2087-97. PubMed ID: 15572196
[TBL] [Abstract][Full Text] [Related]
24. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.
Pozzi OR; Zalutsky MR
J Nucl Med; 2005 Aug; 46(8):1393-400. PubMed ID: 16085599
[TBL] [Abstract][Full Text] [Related]
25. Organoastatine chemistry. Astatination via electrophilic destannylation.
Milius RA; McLaughlin WH; Lambrecht RM; Wolf AP; Carroll JJ; Adelstein SJ; Bloomer WD
Int J Rad Appl Instrum A; 1986; 37(8):799-802. PubMed ID: 3021681
[TBL] [Abstract][Full Text] [Related]
26. A Practical Method for the Preparation of
Zarrad F; Zlatopolskiy BD; Krapf P; Zischler J; Neumaier B
Molecules; 2017 Dec; 22(12):. PubMed ID: 29244780
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma.
Nestor M; Persson M; van Dongen GA; Jensen HJ; Lundqvist H; Anniko M; Tolmachev V
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1296-304. PubMed ID: 16028065
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of glycosylated octreotate analogues labeled with radioiodine and 211At via a tin precursor.
Vaidyanathan G; Affleck DJ; Schottelius M; Wester H; Friedman HS; Zalutsky MR
Bioconjug Chem; 2006; 17(1):195-203. PubMed ID: 16417269
[TBL] [Abstract][Full Text] [Related]
29. Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.
Mairinger S; Stanek J; Wanek T; Langer O; Kuntner C
Appl Radiat Isot; 2015 Oct; 104():124-7. PubMed ID: 26159661
[TBL] [Abstract][Full Text] [Related]
30. Preparation of a 211At-IgG conjugate which is stable in vivo.
Harrison A; Royle L
Int J Appl Radiat Isot; 1984 Nov; 35(11):1005-8. PubMed ID: 6526518
[TBL] [Abstract][Full Text] [Related]
31. Aspects of 6-[18F]fluoro-L-DOPA preparation. Deuterochloroform as a substitute solvent for Freon 11.
Füchtner F; Zessin J; Mäding P; Wüst F
Nuklearmedizin; 2008; 47(1):62-4. PubMed ID: 18278215
[TBL] [Abstract][Full Text] [Related]
32. Alpha-particle track autoradiographic study of the distribution of a [211At]-astatinated drug in normal tissues of the mouse.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1985 Jul; 41(7):925-8. PubMed ID: 4007129
[TBL] [Abstract][Full Text] [Related]
33. Effect of chloroacetyl derivatives of para-substituted phenylalanines on microbial antitumor prescreens.
Otani TT; Briley MR
J Pharm Sci; 1981 Apr; 70(4):464-6. PubMed ID: 6785413
[TBL] [Abstract][Full Text] [Related]
34. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.
Poethko T; Schottelius M; Thumshirn G; Hersel U; Herz M; Henriksen G; Kessler H; Schwaiger M; Wester HJ
J Nucl Med; 2004 May; 45(5):892-902. PubMed ID: 15136641
[TBL] [Abstract][Full Text] [Related]
35. 5-[211 At]astato-2'-deoxyuridine, an alpha particle-emitting endoradiotherapeutic agent undergoing DNA incorporation.
Vaidyanathan G; Larsen RH; Zalutsky MR
Cancer Res; 1996 Mar; 56(6):1204-9. PubMed ID: 8640798
[TBL] [Abstract][Full Text] [Related]
36. Comparative tissue distribution in mice of the alpha-emitter 211At and 131I as labels of a monoclonal antibody and F(ab')2 fragment.
Garg PK; Harrison CL; Zalutsky MR
Cancer Res; 1990 Jun; 50(12):3514-20. PubMed ID: 2340501
[TBL] [Abstract][Full Text] [Related]
37. alpha-Particle track autoradiography for localization of a 211At-astatinated drug.
Mitchell JS; Brown I; Carpenter RN
Experientia; 1983 Mar; 39(3):337-9. PubMed ID: 6825808
[TBL] [Abstract][Full Text] [Related]
38. Method for stabilizing non carrier added 2-[(18)F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation.
Kersemans K; Bauwens M; Mertens J
Nucl Med Biol; 2008 May; 35(4):425-32. PubMed ID: 18482679
[TBL] [Abstract][Full Text] [Related]
39. Halogen-substituted phenylalanines as enantioselective selectors for enantioselective discrimination of amino acids: effect of halogen.
Kumari S; Prabhakar S; Vairamani M
Rapid Commun Mass Spectrom; 2008 May; 22(9):1393-8. PubMed ID: 18384196
[TBL] [Abstract][Full Text] [Related]
40. Radiopharmaceutical chemistry of targeted radiotherapeutics, part 1: effects of solvent on the degradation of radiohalogenation precursors by 211At alpha-particles.
Pozzi OR; Zalutsky MR
J Nucl Med; 2005 Apr; 46(4):700-6. PubMed ID: 15809494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
